Please login to the form below

Not currently logged in
Email:
Password:

Novartis' Constantine Frouzis elected president of Greek pharma body

Takes over at SFEE as industry faces one of its most challenging times

The Hellenic Association of Pharmaceutical Companies (SFEE) has elected Constantine Frouzis to serve as its new president.

Frouzis has worked as vice president and general manager of Novartis Hellas since 2007 and previously contributed to the Greek pharma industry association as its general secretary.

Prior to joining Novartis Frouzis worked across four sectors - telecoms, retail, consumer products and petroleum – for companies including Total, L'Oreal and Vodafon.

He takes the helm of SFEE as the Greek pharma industry faces one of its most challenging times in the last few decades.

Joining Frouzis on SFEE's new 15-member board:

• Galenica's Nikolaos Varelas
• Cana's Vasilis Neiadas
• UCB's Immortality Gioulekas
• Abbott's Paschalis Apostolidis
• GlaxoSmithKline's George Katzourakis
• Genesis Pharma's Costas Evripidis
• Farmaserv Lilly's Spyros Filiotis
• Merck's John Vlontzos
• Winmedica's Marios Kosmidis
• Vian's Costas Panagoulias
• Sanofi's Markos Gerasopoulos
• Rottapharm Hellas' Marios Katsikas
• Janssen's Nikolaos Kefalas
• Boehringer Ingelheim's Konstantinos Economou

Greece is current facing severe economic problems and in February SFEE warned that inflating levels of debt at Greek hospitals could threaten the supply of medicines and even force some pharma companies out of business.

SFEE said its focus now was on ensuring the sustainability of the national health system and pharmaceutical business, and maintaining and strengthening entrepreneurship within both the Greek and multinational companies.

It added that ensuring citizens have access to treatments was “non-negotiable”.

5th April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics